DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 214 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333,388 | +10.6% | 22,572 | -3.3% | 0.00% | +33.3% |
| Q2 2023 | $301,540 | +25.8% | 23,339 | -4.5% | 0.00% | 0.0% |
| Q1 2023 | $239,707 | -9.4% | 24,435 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $264,574 | +8.4% | 24,866 | +6.3% | 0.00% | 0.0% |
| Q3 2022 | $244,000 | -1.6% | 23,401 | +18.6% | 0.00% | 0.0% |
| Q2 2022 | $248,000 | -22.3% | 19,729 | -9.9% | 0.00% | -57.1% |
| Q2 2016 | $319,000 | -24.2% | 21,900 | 0.0% | 0.01% | -22.2% |
| Q1 2016 | $421,000 | -20.9% | 21,900 | -0.5% | 0.01% | -25.0% |
| Q4 2015 | $532,000 | – | 22,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |